What Is the Gonad Cancer Risk in 46,XY DSD? Swyer vs CAIS

The decision about if and when to surgically remove a child’s internal gonads to prevent cancer is deeply personal and strongly influenced by their exact diagnosis. “46,XY differences of sex development” (DSD) is a broad umbrella term. Confirming the specific diagnosis—such as whether a child has Complete Gonadal Dysgenesis (often called Swyer syndrome) or Complete Androgen Insensitivity Syndrome (CAIS)—is critical because the cancer risks and surgical timelines are very different.

Understanding the Difference: Swyer Syndrome vs. CAIS

While both conditions fall under the 46,XY DSD umbrella, they involve different biological pathways that directly impact cancer risk and surgical planning.

Swyer Syndrome: High Risk, Early Planning

In Swyer syndrome, the gonads do not develop properly, leaving undeveloped tissue called “streak gonads” ^[1]. The risk of developing germ cell tumors (abnormal growths starting in the cells meant to form eggs or sperm) in these streak gonads is significantly elevated ^[7].

• Understanding the Risk: Studies summarizing historical and surgical data estimate that between 15% and 60% of these gonads may develop tumors, with specific modern surgical studies finding tumors in approximately 22% to 23% of patients ^[8][7].
• Early Onset and Tumor Types: These growths can appear very early in life, sometimes in children as young as 13 months to 2 years old ^[4][9]. These include gonadoblastoma (which is usually non-invasive but associated with a risk of subsequent malignant cancer) and dysgerminoma (a malignant germ-cell tumor in the gonad) ^[9][4].
• Surgical Timing: Because of the substantial early risk, expert guidelines generally recommend a prophylactic (preventative) gonadectomy (surgical removal of the gonads) promptly after the diagnosis is confirmed ^[9][6]. While not always an immediate emergency, specialists advise prioritizing it in the care plan, frequently before puberty.
• Hormone Replacement: After the gonads are removed, the child will need medically prescribed hormone replacement therapy to induce puberty at the appropriate age and to protect long-term bone and uterine health ^[1][3].

Complete Androgen Insensitivity Syndrome (CAIS): Low Early Risk, Shared Decisions

In CAIS, the child’s androgen receptors do not function normally, meaning their body does not respond to male hormones (androgens) ^[2]. The gonads produce testosterone, but a portion of it is naturally converted into estrogen, which drives spontaneous pubertal development (such as breast growth) ^[2].

• Understanding the Risk: The risk of invasive cancer before puberty is exceptionally low. In large reviews of pathology specimens from CAIS patients, the overall rate of malignant lesions was roughly 1.3% to 1.5%, and virtually all of these occurred after puberty ^[5][10]. Microscopic pre-cancerous cells (germ cell neoplasia in situ) are found in about 6% of cases, again predominantly post-puberty ^[5][10].
• Surgical Timing: Because the childhood risk is low, modern clinical practice often supports deferring gonadectomy until late adolescence or early adulthood ^[2][11].
• Benefits and Trade-offs: Deferring surgery allows the young person to experience spontaneous pubertal development and gives them the opportunity to participate in the irreversible surgical decision when they are older ^[12][2]. However, whenever the gonads are eventually removed, the patient will then need lifelong hormone replacement therapy for bone health and general wellbeing ^[2].
• The Limits of Surveillance: If gonads are retained, an individualized monitoring plan is required ^[12]. While ultrasound or MRI might detect a mass, there is no universally validated imaging schedule, and scans cannot reliably detect microscopic pre-cancerous cells ^[11][10]. Therefore, a “clear” scan does not completely eliminate the risk, and any new symptoms (like groin swelling or persistent pain) require prompt medical evaluation.

Building Your Care Team

Because 46,XY DSDs involve complex, individualized care, it is vital to work with a multidisciplinary DSD team. This team should include pediatric endocrinologists, experienced urologists or gynecologic surgeons, geneticists, and mental health professionals who can support your family and involve your child in age-appropriate ways.